Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;

Validation of the animal naming test for diagnosing minimal hepatic encephalopathy A.D. Cano-Contreras; J.A. Velarde-Ruiz Velasco; F. Higuera-de-la-Tijera; C.F. Castillo-Diaz; D. Grajales-Velázquez; I. Méndez-Ruiz; V.A. Jiménez-Hernández; R. Aguirre-Lázaro; J.A. Sánchez-Hernández; H.R. Ordaz-Álvarez; J.M. Remes-Troche;

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R. Bernal-Reyes; M.E. Icaza-Chávez; L.A. Chi-Cervera; J.M. Remes-Troche; M. Amieva-Balmori; B.A. Priego-Parra; S. Martínez-Vázquez; I.O. Méndez-Guerrero; L. Martínez-Rodríguez; A. Barranca-Enríquez; C. Palmeros-Exsome; A.D. Cano-Contreras; A. Triana-Romero;